Skip to main content

Table 2 Frequencies of APOBEC3G gene polymorphisms (cases vs. controls)

From: HBV/HIV co-infection and APOBEC3G polymorphisms in a population from Burkina Faso

     

HIV (+) versus HIV(−)/HBV(−)

HBV(+) versus HIV(−)/HBV(−)

HIV(+)/HBV(+) versus HIV(−)/HBV(−)

Polymorphisms

HIV(+)

HBV(+)

HIV(+)/HBV(+)

HIV(−)/HBV(−)

OR

95 % CI

p-Value

OR

95 % CI

p-Value

OR

95 % CI

p-Value

 

(n = 35)

(n = 65)

(n = 85)

(n = 239)

         

rs6001417

             

 CC, n (%)

10 (28.57)

15 (0.23)

26 (30.59)

64 (0.27)

1.09

0.5–2.4

0.84

0.82

0.43–1.56

0.63

1.2

0.7–2.07

0.57

 CG, n (%)

17 (48.57)

40 (0.61)

48 (56.47)

114 (0.48)

1.03

0.51–2.1

1

1.75

1.01–3.07

0.05

1.47

0.89–2.42

0.13

 GG, n (%)

8 (22.86)

10 (0.15)

11 (12.94)

61 (0.25)

0.415

0.37–2

0.84

0.415

0.37–2

0.84

0.415

0.207–0.83

0.02

 G vs C, n (%)

33 (0.94)

60 (.92)

35 (0.41)

236 (0.99)

0.9

0.55–1.51

0.8

0.82

0.55–1.2

0.32

0.759

0.5–1.06

0.06

 HWE

0.74

0.16

0.20

0.38

–

–

–

–

–

–

–

–

–

rs8177832

             

 AA. n (%)

10 (28.57)

15 (0.23)

27 (31.76)

69 (28.87)

0.98

0.45–2.16

1

0.74

0.39–1.4

0.43

1.15

0.67–1.96

0.7

 AG. n (%)

18 (0.51)

40 (0.61)

45 (52.94)

111 (0.46)

1.22

0.60–2.48

0.59

1.84

1.05–3.23

0.04

1.34

0.82–2.2

0.26

 GG. n (%)

7(0.2)

10 (0.15)

13 (15.30)

59 (0.25)

0.76

0.32–1.84

0.67

0.55

0.26–1.15

0.13

0.53

0.28–1.02

0.07

 G vs A. n (%)

32 (0.91)

60 (0.92)

36 (42.35)

229 (0.96)

0.9

0.55–1.51

0.8

0.82

0.55–1.2

0.32

0.77

0.54–1.09

0.15

 HWE

0.98

0.16

0.59

0.21

–

–

–

–

–

–

–

–

–

rs35228531

             

 CC. n (%)

18 (0.51)

18 (0.51)

40 (47.05)

84 (35.15)

1.95

0.96–4

0.09

1.15

0.65–2.03

0.66

1.64

0.99–2.71

0.07

 CT. n (%)

15 (0.43)

15 (0.43)

38 (44.70)

113 (0.47)

0.84

0.4–1.71

0.17

0.95

0.55–1.65

0.89

0.93

0.57–1.53

0.80

 TT. n (%)

2 (0.06)

2 (0.06)

7 (8.25)

42 (0.17)

0.28

0.06–1.23

0.09

0.85

0.40–1.80

0.85

0.4

0.17–0.9

0.04

 T vs C. n (%)

19 (0.54)

19 (0.54)

25 (29.88)

197 (0.82)

0.53

0.3–0.93

0.03

0.89

0.6–1.33

0.615

0.61

0.42–0.90

0.01

 HWE

0.88

0.98

0.86

0.55

–

–

–

–

–

–

–

–

–

  1. HWE Hardy-Weinberg equilibrium, OR odds ratio, CI confidence interval. Significant p-Values are in bold
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us